APRIL, which is expressed at low levels by normal cells,[29], [30] is upregulated on B-cell chronic lymphocytic leukemia (CLL), lymphoma and myeloma cells ([14], reviewed in [31]), i.e. malignancies involving late-stage B-cells. Here, TNFSF13 is linked to lymphoma.